NCT04839367View on ClinicalTrials.gov

Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

October 19, 2022

Study Completion Date

October 19, 2022

Conditions
Prostatic Neoplasms
Interventions
DRUG

64Cu-SAR-bisPSMA

64Cu-SAR-bisPSMA

Trial Locations (3)

2010

St. Vincent's Hospital, Sydney

2751

Nepean Hospital, Kingswood

6150

GenesisCare CTA, SJOG Medical Clinic, Murdoch

Sponsors
All Listed Sponsors
lead

Clarity Pharmaceuticals Ltd

INDUSTRY